Obesity
Not recruitingEfficacy and Safety of MET097 Once Weekly in People with Overweight or Obesity and Type 2 Diabetes
- Disease:Obesity
- Substances:–
Germany- Participants:18–64 years · 65+ years
- Sponsor:Metsera Inc.
Rare diseases
Investigational molecules
Locations
Beselerstrasse, 2a, 22607 Hamburg, Germany
Diabeteszentrum Hamburg-West in Hamburg, Germany specialises in clinical trials of conditions such as Obesity, and other specialisations. This site conducts important research.
The Diabeteszentrum Hamburg-West conducts focused clinical research on obesity and related metabolic conditions, aiming to improve weight management strategies.
These studies test the efficacy of the novel agent MET097, seeking to demonstrate superior weight loss compared with placebo, and contribute to advancing treatment options for metabolic disease.
Clinical trials registered at this site – none is enrolling right now.
Germany
GermanyGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.